AbCellera Biologics (ABCL) Treasury Shares (2021 - 2026)
AbCellera Biologics' (ABCL) quarterly Treasury Shares came in at $10.1 million in Q1 2026, up 4.2% YoY from $9.7 million in Q1 2025, and up 12.61% on a QoQ basis from $9.0 million in Q3 2025.
AbCellera Biologics (ABCL) Treasury Shares (2021 - 2026) Analysis & Trends
AbCellera Biologics (ABCL) has 6 years of Treasury Shares data on file, last reported at $10.1 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 36.40 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 5.08 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.72 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 92,219.00 |
| 10 | AbCellera Biologics | 3.49 Bn | 3.49 Bn | - | 9.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 9.84 Mn |
| Jun 30, 2026 | 9.84 Mn |
| Mar 31, 2026 | 10.14 Mn |
| Mar 31, 2026 | 10.14 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Sep 30, 2025 | 9.00 Mn |
| Jun 30, 2025 | 9.39 Mn |
| Jun 30, 2025 | 9.39 Mn |
| Mar 31, 2025 | 9.73 Mn |
| Mar 31, 2025 | 9.73 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Sep 30, 2024 | 6.85 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Jun 30, 2024 | 7.03 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Mar 31, 2024 | 7.10 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Sep 30, 2023 | 4.42 Mn |
| Jun 30, 2023 | 4.59 Mn |
| Jun 30, 2023 | 4.59 Mn |